(Q58840803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Omalizumab therapy in severe asthma: experience from the Spanish registry--some new approaches (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

Juan Francisco Medina Gallardo

26 January 2020

1 reference

ORCID Public Data File 2021

author name string

María Del Carmen Vennera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Luis Pérez De Llano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Santiago Bardagí

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Pilar Ausin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Carles Sanjuas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Héctor González

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Eva Martínez-Moragón

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Elisabet Vera

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Alicia Padilla

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Rosa Irigaray

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

César Picado

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

José A Carretero

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Juan F Medina

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Francisco J Alvarez

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Luis M Entrenas

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Spanish Registry

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

English

0 references

publication date

23 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

416-422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

Effectiveness of omalizumab (Xolair) in the first patients treated in real-life practice in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

"Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

Italian real-life experience of omalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

The use of omalizumab in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

Effects of omalizumab in Aspergillus-associated airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

Rhinosinusitis and asthma: a link for asthma severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.668255

10.3109/02770903.2012.668255

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22443408%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference